Skip to Main Content

Paper Details

Combined action of the dinuclear platinum compound BBR3610 with the PI3-K inhibitor PX-866 in glioblastoma.
Int J Cancer
20
2011
BBR3610, PI3-K, PI3K, PX-866, brain tumor, cisplatin, cultured glioma cells, glioblastoma, glioblastoma cells, glioma, pAkt, pBad, phosphoinositide-3-kinase, platinum, platinums, tumor
Animals, Apoptosis, Autophagy, Blotting, Western, Brain Neoplasms, Cell Adhesion, Cell Cycle, Cell Movement, Cell Proliferation, Drug Synergism, Drug Therapy, Combination, Glioma, Gonanes, Humans, Male, Mice, Mice, Nude, Organoplatinum Compounds, Phosphoinositide-3 Kinase Inhibitors, Proto-Oncogene Proteins c-akt, RNA, Messenger, Reverse Transcriptase Polymerase Chain Reaction, Signal Transduction, Survival Rate, Tumor Cells, Cultured
Author NameAffiliation
Ho-Shin GwakUniversity of Texas MD Anderson Cancer Center
  • 1 - 1

Datasets

Release 1.2